Recently, a new approach for direct protein transfer to mammalian cells bas
ed on the herpes simplex virus type 1 protein VP22 has been described. This
protein has the remarkable property of intercellular trafficking, which is
independent of direct cell contacts and is also retained when fused to het
erologous proteins. However, the spreading has only been described for prol
iferating cells and has also been controversially discussed. In this study
we describe the generation of a GFP-VP22 fusion protein which is able to sp
read in COS-7 cells after transient transfection. Moreover, we show in cocu
lture experiments with transfected COS-7 cells and C2C12 myotubes that this
fusion protein is also able to spread into terminally differentiated skele
tal muscle cells. These results suggest that VP22 might be a novel therapeu
tic tool for direct protein transfer not only in proliferating but also in
terminally differentiated cells.